DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Gauthier, A. [1 ]
Kanis, J. A. [2 ]
Martin, M. [3 ]
Compston, J. [4 ]
Borgstrom, F. [5 ]
Cooper, C. [6 ]
机构：
[1] Amaris, London, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] i3 Innovus, Uxbridge, Middx, England
[4] Univ Cambridge, Cambridge, Cambs, England
[5] i3 Innovus, Stockholm, Sweden
[6] Univ Southampton, Southampton, Hants, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75236-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A452 / A452
页数：1
相关论文
共 50 条
  • [1] Development and validation of a disease model for postmenopausal osteoporosis
    Gauthier, A.
    Kanis, J. A.
    Martin, M.
    Compston, J.
    Borgstrom, F.
    Cooper, C.
    McCloskey, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 771 - 780
  • [2] Development and validation of a disease model for postmenopausal osteoporosis
    A. Gauthier
    J. A. Kanis
    M. Martin
    J. Compston
    F. Borgström
    C. Cooper
    E. McCloskey
    [J]. Osteoporosis International, 2011, 22 : 771 - 780
  • [3] Development and validation of osteoporosis prescreening model for Iranian postmenopausal women
    Matin N.
    Tabatabaie O.
    Keshtkar A.
    Yazdani K.
    Asadi M.
    [J]. Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [4] Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women
    Sun Min Oh
    Byung-Ho Nam
    Yumie Rhee
    Seong-Hwan Moon
    Deog Young Kim
    Dae Ryong Kang
    Hyeon Chang Kim
    [J]. Journal of Bone and Mineral Metabolism, 2013, 31 : 423 - 432
  • [5] Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women
    Oh, Sun Min
    Nam, Byung-Ho
    Rhee, Yumie
    Moon, Seong-Hwan
    Kim, Deog Young
    Kang, Dae Ryong
    Kim, Hyeon Chang
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (04) : 423 - 432
  • [6] Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis
    Yuan, W.
    Yang, M.
    Zhu, Y.
    [J]. BONE & JOINT RESEARCH, 2022, 11 (08): : 548 - 560
  • [7] VALIDATION OF A BUDGET IMPACT MODEL FOR USE OF DENOSUMAB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Mehta, D.
    Stolshek, B.
    Agodoa, I
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A157 - A157
  • [8] DEVELOPMENT OF A MECHANISM-BASED DRUG-DISEASE MODEL TO QUANTIFY POSTMENOPAUSAL OSTEOPOROSIS.
    Madrasi, K.
    Samant, S.
    Kim, M.
    Li, F.
    Voss, S.
    Kehoe, T.
    Schmidt, S.
    Li, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S105 - S105
  • [9] DEVELOPMENT AND VALIDATION OF A HEALTH ECONOMIC MODEL FOR CORTICOSTEROID-INDUCED OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS IN JAPAN
    Moriwaki, K.
    Noto, S.
    Yanagisawa, S.
    Ito, S.
    Toujou, T.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A645 - A645
  • [10] PREDICTORS OF THE DEVELOPMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Yermolenko, Tetyana
    Ignatyev, Oleksandr
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 405 - 405
12345